SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019016
Filing Date
2023-11-14
Accepted
2023-11-14 16:05:49
Documents
15
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20231114x8k.htm   iXBRL 8-K 36523
2 EX-99.1 armp-20231114xex99d1.htm EX-99.1 184936
3 GRAPHIC armp-20231114xex99d1001.jpg GRAPHIC 2307
  Complete submission text file 0001558370-23-019016.txt   363836

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20231114.xsd EX-101.SCH 3933
5 EX-101.DEF armp-20231114_def.xml EX-101.DEF 2864
6 EX-101.LAB armp-20231114_lab.xml EX-101.LAB 16599
7 EX-101.PRE armp-20231114_pre.xml EX-101.PRE 10923
9 EXTRACTED XBRL INSTANCE DOCUMENT armp-20231114x8k_htm.xml XML 4702
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 231405925
SIC: 2836 Biological Products, (No Diagnostic Substances)